Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer
Anticancer Research · 2026
DOI: 10.21873/anticanres.18206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yutaka Yamamoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kindai University Nara Hospital, Nara, Japan. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant.
Abstract (Originalsprache)
BACKGROUND/AIM: Oncological outcomes for metastatic castration-sensitive prostate cancer (mCSPC) have improved with upfront androgen receptor signaling inhibitor (ARSI) doublet therapy. However, the prognostic value of prostate-specific antigen (PSA) kinetics in real-world settings remains unclear. This study aimed to evaluate the clinical significance of PSA kinetics in patients with high-risk mCSPC. PATIENTS AND METHODS: We retrospectively analyzed 352 patients with high-risk mCSPC from the ULTRA-J database who received upfront ARSI doublet therapy between 2018 and 2023. PSA kinetics, including PSA nadir, PSA response rate, and time to PSA nadir (TTN), were assessed. Associations with castration-resistant prostate cancer-free survival (CRPC-FS) and overall survival (OS) were evaluated using Kaplan-Meier analysis and Cox proportional hazards models. RESULTS: A PSA nadir ≤0.02 ng/ml and PSA response rate ≥99% were significantly associated with prolonged CRPC-FS and OS (p 0.02 ng/ml, PSA response rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kindai University Nara Hospital, Nara, Japan.
- Department of Urology, Kindai University Hospital, Osaka, Japan.
- Department of Urology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
- Department of Urology, The Jikei University Hospital, Tokyo, Japan.
- Department of Urology, Fujita Health University Hospital, Aichi, Japan.
- Department of Urology, Kawasaki Medical School, Okayama, Japan.
Zitieren
APA
Yamamoto, Y., Matsumura, N., Fujimoto, S., Morita, T., Uchimoto, T., Fukuokaya, W., Saruta, M., Sugiyama, S., Tamura, K., Azuma, H., Kimura, T., Takahara, K., Komura, K., Inamoto, T., & Fujita, K. (2026). Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18206
Vancouver
Yamamoto Y, Matsumura N, Fujimoto S, Morita T, Uchimoto T, Fukuokaya W, et al. Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18206
BibTeX
@article{Yamamoto2026,
author = {Yamamoto, Yutaka and Matsumura, Naoki and Fujimoto, Saizou and Morita, Tsuyoshi and Uchimoto, Taizo and Fukuokaya, Wataru and Saruta, Masanobu and Sugiyama, Seitetsu and Tamura, Keita and Azuma, Haruhito and Kimura, Takahiro and Takahara, Kiyoshi and Komura, Kazumasa and Inamoto, Teruo and Fujita, Kazutoshi},
title = {Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18206}
}
EUVIMED